Home     About SABCS     Press Releases     Media     Event Photos     Past Symposia     Satellite Symposia     Patient Advocates     FAQs     Contact Us



Registration           Hotel           Late Breaking Abstract Submission     Support & Exhibits     2014 Overview           Program           Travel & Transportation          

Quick Links
Career Development Forum Reg Form
SABCS 2013 Program Book pdf

Schedule at a Glance
 
Daily Schedule:
Tue. 12/9/2014
Wed. 12/10/2014
Thu. 12/11/2014
Fri. 12/12/2014
Sat. 12/13/2014
 
Poster Sessions:
Poster Session 1
Poster Session 2
Poster Session 3
Poster Session 4
Poster Session 5
Poster Session 6
 
Poster Session OT1
Poster Session OT2
Poster Session OT3
 
Poster Discussions:
Poster Discussion 1
Poster Discussion 2
Poster Discussion 3
Poster Discussion 4
Poster Discussion 5
Poster Discussion 6
 

Program Schedule   >  Poster Sessions - Poster Discussion 6

Poster Discussion 6 
   
  Circulating Tumor Cells
PD6-1 Tumor spheres growing from peripherally circulating tumor cells exhibit stem cell features
Pachmann K, Zimon D, Pizon M, Pachmann U. Transfusion Center, Bayreuth, Germany.
PD6-2 Identifying genomic signatures in circulating tumour cells from breast cancer
Kanwar N, Hu P, Bedard P, Clemons M, McCready D, Done SJ. Campbell Family Institute for Breast Cancer Research, Toronto, ON, Canada; University of Toronto, Toronto, ON, Canada; The Center for Applied Genomics, Toronto, ON, Canada; University Health Network, Toronto, ON, Canada; The Ottawa Hospital Cancer Center, Ottawa, ON, Canada; Laboratory Medicine Program, University Health Network, Toronto, ON, Canada.
PD6-3 Comparison of the HER2, estrogen and progesterone receptor expression profile of primary tumor, metastases and circulating tumor cells in metastatic breast cancer patients
Aktas B, Kasimir-Bauer S, Mueller V, Rack B, Janni W, Pantel K, Fehm T, Tewes M. University Hospital Essen, Essen, Germany; Univerity Hospital Hamburg-Eppendorf, Hamburg, Germany; University Hospital Muenchen, Muenchen, Germany; University Hospital Ulm, Ulm, Germany; University Hospital Hamburg-Eppendorf, Hamburg, Germany; University Hospital Duesseldorf, Duesseldorf, Germany; University Hospital Essen, West German Cancer Center, Essen, Germany.
PD6-4 Heterogeneity of expression of estrogen receptor by circulating tumor cells suggests diverse mechanisms of resistance to fulvestrant in metastatic breast cancer patients
Paoletti C, Muņiz MC, Aung K, Larios J, Thomas DG, Tokudome N, Brown ME, Connelly MC, Chianese DA, Schott AF, Henry NL, Rae JM, Hayes DF. University of Michigan Comprehensive Cancer Center, Ann Arbor, MI; Veridex, LLC, Huntingdon Valley, PA.
PD6-5 Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data
Bidard F-C, Peeters D, Fehm T, Nole F, Gisbert-Criado R, Mavrudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, Antelo M-L, de Mattos-Arruda L, Ignatiadis M, Lebofsky R, van Laere SJ, Meier-Stiegen F, Sandri M-T, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson S-J, Raimondi C, Rutten A, Janni W, Munzone E, Caranana V, Agelaki S, Almici C, Dirix L, Solomayer E, Zorzino L, Johannes H, Reis-Filho J, Pantel K, Pierga J-Y, Michiels S. Institut Curie, Paris, France; GZA Hospitals Sint-Augustinus, Antwerp, Belgium; University Medical Center, Duesseldorf, Germany; European Institute of Oncology, Milan, Italy; Hospital Arnau de Vilanova, Valencia, Spain; University Hospital of Heraklion, Heraklion, Greece; Public Hospitals of Brescia, Brescia, Italy; Hospital Institute of Cremona, Cremona, Italy; Hospital Clinico San Carlos, Madrid, Spain; Imperial College, London, United Kingdom; University of Cambridge, Cambridge, United Kingdom; Sapienza University of Rome, Rome, Italy; University Hospital 12 de Octubre, Madrid, Spain; Venetian Institute of Oncology, Padua, Italy; Hospital de Navarra, Pamplona, Spain; Val d'Hebron Institute of Oncology, Barcelona, Spain; Institut Jules Bordet, Brussels, Belgium; University Medical Center, Tuebingen, Germany; University Medical Center, Ulm, Germany; University of Saarland, Homburg, Germany; IDDI - International Drug Development Institute, Louvain-La-Neuve, Belgium; Memorial Sloan-Kettering Cancer Center, New-York; University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Institut Gustave Roussy, Villejuif, France. Francois-Clement Bidard is a recipient of an SABCS Clinical Scholars scholarship
PD6-6 A pooled analysis of the prognostic relevance of circulating tumor cells in early breast cancer
Janni WJ, Rack BK, Terstappen LMWW, Pierga J-Y, Fehm T, Hall C, Groot M, Bidard F-C, Meier-Stiegen F, Friedl TWP, Fasching P, Lucci A. Universitaetsfrauenklinik, Ulm, Germany; Universitaetsfrauenklinik, LMU Munich, Germany; Twente University, Enschede, Netherlands; Institut Curie & Universite Paris Descartes, Paris, France; Heinrich-Heine University, Duesseldorf, Germany; MD Anderson Cancer Center, Houston; Medisch Spectrum, Enschede, Netherlands; Universitaetsfrauenklinik, Tuebingen, Germany; Universitaetsfrauenklinik, Erlangen, Germany.
PD6-7 The prognostic relevance of disseminated tumor cells (DTC) form the bone marrow (BM) in different molecular subtypes of primary breast cancer (PBC) patients
Hartkopf AD, Taran F-A, Brucker S, Hahn M, Wallwiener D, Becker S, Solomayer E-F, Wallwiener M, Fehm T. University of Tuebingen, Tuebingen, Germany; University of Heidelberg, Heidelberg, Germany; University of Duesseldorf, Duesseldorf, Germany; University of Frankfurt, Frankfurt, Germany; Saarland University, Homburg, Germany.
PD6-8 Prognostic value of disseminated tumor cells according to ER/PR and HER2 status in non-metastatic breast cancer
Lee JS, Magbanua MJM, Moore AP, Esserman LJ, Park JW. University of California San Francisco, San Francisco, CA.
   
 
Home | About SABCS | Press Releases | Media | Event Photos | Past Symposia | Satellite Symposia | Patient Advocates | FAQs | Contact Us
Registration | Hotel | Support & Exhibits | 2014 Overview | Program | Travel & Transportation

Rich Markow, Director, Symposia
Cancer Therapy & Research Center at UT Health Science Center San Antonio

7979 Wurzbach Road, MC 8224 San Antonio, TX 78229 USA
Phone: 210-450-1550    Fax: 210-450-1560    Email: sabcs@uthscsa.edu
       line
Copyright Š 2014 SABCS. All rights reserved. - Privacy Policy